Searched for
MUCINEX
Reckitt posts double-digit growth in India business for Q1Reckitt's India operations achieved double-digit growth in the first quarter of 2026. Key brands such as Dettol and Durex performed strongl...- The AI boom has an unlikely early winner: Wonky consultantsAs the tech industry explores avenues to monetise generative AI, consultants have already started capitalising on its potential profitabili...
- CVS removes popular cough and cold medicines from store shelvesCVS has removed popular oral cough and cold medicines like Sudafed, Mucinex, Vicks, Allegra, and Dayquil from its stores. The FDA advisory ...
- Starbucks gets a taste of India with Laxman Narasimhan as bossAssociates who've worked with Narasimhan call out his core strengths in operations and finance, and his ability to connect across managemen...
- Looking at every opportunity in India to provide full range of products: RB CEORB sells a range of hygiene products in India including Dettol, Lizol, Harpic, while in health it has some popular brands as Disprin and St...
- Granules India gets tentative nod from USFDA for expectorant tabletsGranules India stock was trading at Rs 162.65 apiece, up 2.07 per cent, on the BSE.
- Aurobindo Pharma gets USFDA nod for its expectorant tabletsThe company has received final approval from the United States Food and Drug Administration (USFDA) to manufacture its generic Guaifenesin ...
- Meet a new generation of rising stars of the Indian diaspora making a mark in diverse fields around the worldTogether, they are the single biggest remittance group — sending $80 billion home in 2018 alone.
- Dr Reddys launches anti-phlegm OTC drug in US marketOTC Guaifenesin and Pseudoephedrine HCl is used to help loosen phlegm (mucus) and thin bronchial secretions.
- Reckitt Benckiser Group Plc names Laxman Narasimhan as global CEONarasimhan to replace another Indian, Rakesh Kapoor, at the British firm.
- Reckitt Benckiser looking to sell some non-core brands like Robin Blue, Robinson BarleyThough the sales of these brands have been falling for the past few years, analysts say it can still fetch a significant premium, given the...
- Reckitt's Rakesh Kapoor makes a mark with focus on consumer healthcareThough Kapoor still faces challenges with the home-care division and slowing growth in some emerging markets, the stock has risen 60% since...
- Reckitt Benckiser India to buy around 26% stake in Healthcare unit for Rs 725 croreReckitt Benckiser India plans to buy around 26% stake in its sister firm Reckitt Benckiser Healthcare for Rs 725 crore.
- Reckitt Benckiser India adds healthcare to its homecare portfolio; jury mulls whether it made right callReckitt Benckiser India adds healthcare to its homecare portfolio with vigour and aggression, but the jury is still out on whether it made ...
- Healthcare will be one-third of our revenues in 3-4 years: Chander Mohan Sethi, Reckitt BenckiserIn an extensive interview, Chander Mohan Sethi, Reckitt Benckiser India's managing director and regional director for South & South East As...
Load More
